fda warning letters compounded semaglutide tirzepatide september 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and "kits" September 15, 2025: Telehealth company

Eliminate sugary snacks and processed carbs

Bell joins hundreds of other consumers now pursuing Ozempic stomach paralysis lawsuits against Novo Nordisk, as well as Wegovy lawsuits, Mounjaro lawsuits and other claims against manufacturers of similar drugs marketed in recent years for treatment of diabetes and weight loss, which are known as glucagon-like peptide-1 (GLP-1) receptor agonists

For context, 22.5% from 250 lbs is approximately 56 lbs

[DOI] [PMC free article] [PubMed] 6.Prasad-Reddy L, Isaacs D

Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication

With today's approval of the Wegovy pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection, Mike Doustdar, president and CEO of Novo Nordisk said in the release